DNA synthesis is the natural or artificial creation of deoxyribonucleic acid (DNA) molecules. DNA is a macromolecule made up of nucleotide units, which are linked by covalent bonds and hydrogen bonds, in a repeating structure.
The global Oligonucleotide Synthesis and Gene Synthesis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Oligonucleotide Synthesis and Gene Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oligonucleotide Synthesis and Gene Synthesis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oligonucleotide Synthesis and Gene Synthesis in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oligonucleotide Synthesis and Gene Synthesis include Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), BBI, Azenta Life Sciences, SBS Genetech, Bio Basic, Twist Bioscience, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Synthesis and Gene Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Synthesis and Gene Synthesis.
The Oligonucleotide Synthesis and Gene Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide Synthesis and Gene Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Synthesis and Gene Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
Segment by Type
Oligonucleotide Synthesis
Gene Synthesis
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Synthesis and Gene Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oligonucleotide Synthesis
1.2.3 Gene Synthesis
1.3 麻豆原创 by Application
1.3.1 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Perspective (2019-2030)
2.2 Global Oligonucleotide Synthesis and Gene Synthesis Growth Trends by Region
2.2.1 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oligonucleotide Synthesis and Gene Synthesis Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Oligonucleotide Synthesis and Gene Synthesis Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Dynamics
2.3.1 Oligonucleotide Synthesis and Gene Synthesis Industry Trends
2.3.2 Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Drivers
2.3.3 Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Challenges
2.3.4 Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Synthesis and Gene Synthesis Players by Revenue
3.1.1 Global Top Oligonucleotide Synthesis and Gene Synthesis Players by Revenue (2019-2024)
3.1.2 Global Oligonucleotide Synthesis and Gene Synthesis Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Synthesis and Gene Synthesis Revenue
3.4 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Concentration Ratio
3.4.1 Global Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis and Gene Synthesis Revenue in 2023
3.5 Global Key Players of Oligonucleotide Synthesis and Gene Synthesis Head office and Area Served
3.6 Global Key Players of Oligonucleotide Synthesis and Gene Synthesis, Product and Application
3.7 Global Key Players of Oligonucleotide Synthesis and Gene Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Synthesis and Gene Synthesis Breakdown Data by Type
4.1 Global Oligonucleotide Synthesis and Gene Synthesis Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Oligonucleotide Synthesis and Gene Synthesis Forecasted 麻豆原创 Size by Type (2025-2030)
5 Oligonucleotide Synthesis and Gene Synthesis Breakdown Data by Application
5.1 Global Oligonucleotide Synthesis and Gene Synthesis Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Oligonucleotide Synthesis and Gene Synthesis Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size (2019-2030)
6.2 North America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2019-2024)
6.4 North America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size (2019-2030)
7.2 Europe Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2019-2024)
7.4 Europe Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size (2019-2030)
9.2 Latin America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Oligonucleotide Synthesis and Gene Synthesis 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Oligonucleotide Synthesis and Gene Synthesis Introduction
11.1.4 Genescript Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.1.5 Genescript Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Oligonucleotide Synthesis and Gene Synthesis Introduction
11.2.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 IDT
11.3.1 IDT Company Details
11.3.2 IDT Business Overview
11.3.3 IDT Oligonucleotide Synthesis and Gene Synthesis Introduction
11.3.4 IDT Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.3.5 IDT Recent Development
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Details
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Oligonucleotide Synthesis and Gene Synthesis Introduction
11.4.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.4.5 Eurofins Genomics Recent Development
11.5 DNA 2.0 (ATUM)
11.5.1 DNA 2.0 (ATUM) Company Details
11.5.2 DNA 2.0 (ATUM) Business Overview
11.5.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis and Gene Synthesis Introduction
11.5.4 DNA 2.0 (ATUM) Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.5.5 DNA 2.0 (ATUM) Recent Development
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Oligonucleotide Synthesis and Gene Synthesis Introduction
11.6.4 BBI Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.6.5 BBI Recent Development
11.7 Azenta Life Sciences
11.7.1 Azenta Life Sciences Company Details
11.7.2 Azenta Life Sciences Business Overview
11.7.3 Azenta Life Sciences Oligonucleotide Synthesis and Gene Synthesis Introduction
11.7.4 Azenta Life Sciences Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.7.5 Azenta Life Sciences Recent Development
11.8 SBS Genetech
11.8.1 SBS Genetech Company Details
11.8.2 SBS Genetech Business Overview
11.8.3 SBS Genetech Oligonucleotide Synthesis and Gene Synthesis Introduction
11.8.4 SBS Genetech Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.8.5 SBS Genetech Recent Development
11.9 Bio Basic
11.9.1 Bio Basic Company Details
11.9.2 Bio Basic Business Overview
11.9.3 Bio Basic Oligonucleotide Synthesis and Gene Synthesis Introduction
11.9.4 Bio Basic Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.9.5 Bio Basic Recent Development
11.10 Twist Bioscience
11.10.1 Twist Bioscience Company Details
11.10.2 Twist Bioscience Business Overview
11.10.3 Twist Bioscience Oligonucleotide Synthesis and Gene Synthesis Introduction
11.10.4 Twist Bioscience Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.10.5 Twist Bioscience Recent Development
11.11 OriGene
11.11.1 OriGene Company Details
11.11.2 OriGene Business Overview
11.11.3 OriGene Oligonucleotide Synthesis and Gene Synthesis Introduction
11.11.4 OriGene Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.11.5 OriGene Recent Development
11.12 Bioneer
11.12.1 Bioneer Company Details
11.12.2 Bioneer Business Overview
11.12.3 Bioneer Oligonucleotide Synthesis and Gene Synthesis Introduction
11.12.4 Bioneer Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.12.5 Bioneer Recent Development
11.13 Eton Bioscience
11.13.1 Eton Bioscience Company Details
11.13.2 Eton Bioscience Business Overview
11.13.3 Eton Bioscience Oligonucleotide Synthesis and Gene Synthesis Introduction
11.13.4 Eton Bioscience Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.13.5 Eton Bioscience Recent Development
11.14 Synbio Technologies
11.14.1 Synbio Technologies Company Details
11.14.2 Synbio Technologies Business Overview
11.14.3 Synbio Technologies Oligonucleotide Synthesis and Gene Synthesis Introduction
11.14.4 Synbio Technologies Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.14.5 Synbio Technologies Recent Development
11.15 Eurogentec
11.15.1 Eurogentec Company Details
11.15.2 Eurogentec Business Overview
11.15.3 Eurogentec Oligonucleotide Synthesis and Gene Synthesis Introduction
11.15.4 Eurogentec Revenue in Oligonucleotide Synthesis and Gene Synthesis Business (2019-2024)
11.15.5 Eurogentec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
听
听
*If Applicable.
